RPA3 was primarily localized in the nucleus, and its expression was high in 60/104 (57.7%) NPC tissues, whereas it was only high in 2/21 (9.5%) normal nasopharyngeal epithelium samples (P < 0.001; Fig. 5A and B). This evidence concerns the gene RPA3 and nasopharyngeal carcinoma.